QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Apr 2, 2013
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Sale
Common Stock
2013-03-27$11.24/sh−18,374$206,524→ 27,112 total - Award
Common Stock
2013-03-27$11.24/sh+18,374$206,524→ 45,486 total
Footnotes (1)
- [F1]Same-day-sale exercise of stock options issued under an NQSO Grant on July 7, 2005. The stock options vested in four equal installments as follows: July 7, 2006, July 7, 2007, July 7, 2008 and July 7, 2009.